Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS AND CONTINGENCIES - Amended Patent Purchase Agreement (Details Narrative)

v2.4.0.6
COMMITMENTS AND CONTINGENCIES - Amended Patent Purchase Agreement (Details Narrative) (Amended Patent Purchase Agreement with BAXL, USD $)
6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jan. 18, 2005
Amended Patent Purchase Agreement with BAXL
     
Long-term Purchase Commitment [Line Items]      
Additional purchase price paid for restructuring of future contingent payments     $ 500,000
Future contingent payments, Terms Future contingent payments by the Company to Seller of $1.0 million upon achievement of $25 million of Net Royalties (as defined), an additional $1.0 million upon achievement of $50 million of Net Royalties and an additional $500,000 upon achievement of $62.5 million of Net Royalties from licensing or sale of the patents acquired from Seller    
Additional patent expense payable since Net Royalties target of $25 million was achieved   $ 1,000,000